Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

SHE:300181 Revenue

Zhejiang Jolly Pharmaceutical Co.,LTD had revenue of 745.83M CNY in the quarter ending September 30, 2026, with 9.64% growth. This brings the company's total for the last twelve months to 3.27B, up 16.29% year-over-year. In the year 2025, Zhejiang Jolly Pharmaceutical Co.,LTD had annual revenue of 3.04B with 17.96% growth. That makes Zhejiang Jolly Pharmaceutical Co.,LTD the 11,478th largest company in the world by revenue and 1,935th in China.

• Revenue (ttm): 3.27B
• Revenue Growth: +16.29%
• P/S Ratio: 2.73
• Revenue / Employee: 1.14M
• Employees: 2,861
• Market Cap: 8.94B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Manufacturing 2.37B 77.9%
• Pharmaceutical Distribution 662.91M 21.8%
• Unallocated Other Operations 9.77M 0.3%

Fiscal year ended Dec 31, 2025 See the full SHE:300181 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.04B	462.89M	17.96%
Dec 31, 2024	2.58B	635.44M	32.71%
Dec 31, 2023	1.94B	137.29M	7.61%
Jan 1, 2023	1.81B	347.76M	23.86%
Jan 1, 2022	1.46B	366.52M	33.60%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error